Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1991
External irradiation prior to conservative surgery for breast cancer treatment
E Calitchi, Y Otmezguine, F Feuilhade, et al.
Pathologie-Biologie
|
October 1, 1990
[Consensus and controversies in conservative treatment indications]
E Calitchi, Y Otmezguine, F Feuilhade, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 1, 1996
Interleukin-2 in outpatients with renal cell carcinoma: SCAPP1 trial
J M Tourani, P Grise, V Lucas, et al.
Cell Systems
|
March 31, 2023
Entropic analysis of antigen-specific CDR3 domains identifies essential binding motifs shared by CDR3s with different antigen specificities
Alexander M Xu, William Chour, Diana C DeLucia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trial
J M Tourani, V Lucas, D Mayeur, et al.
Bulletin Du Cancer
|
April 1, 1997
[Subcutaneous administration of interleukin-2 in ambulatory treatment of patients with metastatic renal cancer. Three-year results of the SCAPP I program]
J M Tourani, C Jaillon-Abraham, V Lucas, et al.
International Journal of Molecular Sciences
|
September 28, 2023
A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination
Dalin Li, Ana Jimena Pavlovitch-Bedzyk, Joseph E Ebinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group
J M Tourani, C Pfister, J F Berdah, et al.
Nature Biotechnology
|
September 7, 2021
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19
Jihoon W Lee, Yapeng Su, Priyanka Baloni, et al.
Science Immunology
|
February 10, 2023
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals
Harry B Gristick, Harald Hartweger, Maximilian Loewe, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
International Journal of Radiation Oncology, Biology, Physics
|
July 1, 1991
External irradiation prior to conservative surgery for breast cancer treatment
E Calitchi, Y Otmezguine, F Feuilhade, et al.
Pathologie-Biologie
|
October 1, 1990
[Consensus and controversies in conservative treatment indications]
E Calitchi, Y Otmezguine, F Feuilhade, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
October 1, 1996
Interleukin-2 in outpatients with renal cell carcinoma: SCAPP1 trial
J M Tourani, P Grise, V Lucas, et al.
Cell Systems
|
March 31, 2023
Entropic analysis of antigen-specific CDR3 domains identifies essential binding motifs shared by CDR3s with different antigen specificities
Alexander M Xu, William Chour, Diana C DeLucia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trial
J M Tourani, V Lucas, D Mayeur, et al.
Bulletin Du Cancer
|
April 1, 1997
[Subcutaneous administration of interleukin-2 in ambulatory treatment of patients with metastatic renal cancer. Three-year results of the SCAPP I program]
J M Tourani, C Jaillon-Abraham, V Lucas, et al.
International Journal of Molecular Sciences
|
September 28, 2023
A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination
Dalin Li, Ana Jimena Pavlovitch-Bedzyk, Joseph E Ebinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group
J M Tourani, C Pfister, J F Berdah, et al.
Nature Biotechnology
|
September 7, 2021
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19
Jihoon W Lee, Yapeng Su, Priyanka Baloni, et al.
Science Immunology
|
February 10, 2023
CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals
Harry B Gristick, Harald Hartweger, Maximilian Loewe, et al.
Page
of 8